<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29021456</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1349-7235</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>23</Issue><PubDate><Year>2017</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Internal medicine (Tokyo, Japan)</Title><ISOAbbreviation>Intern Med</ISOAbbreviation></Journal><ArticleTitle>Quantitative Assessment of Swallowing Dysfunction in Patients with Spinal and Bulbar Muscular Atrophy.</ArticleTitle><Pagination><StartPage>3159</StartPage><EndPage>3165</EndPage><MedlinePgn>3159-3165</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2169/internalmedicine.8799-16</ELocationID><Abstract><AbstractText>Objective This study aimed to evaluate swallowing dysfunction in patients with spinal and bulbar muscular atrophy and to identify the most appropriate method of assessing swallowing dysfunction using a videofluoroscopic swallowing study. Methods In the videofluoroscopic swallowing study, patients were instructed to swallow 3 mL of 40% weight/volume barium sulfate twice, and the pharyngeal residue was measured. We used three different methods to quantify the pharyngeal barium residue and an eight-point scale to evaluate the laryngeal penetration leading to aspiration pneumoniae. Patients We assessed 111 patients with spinal and bulbar muscular atrophy who weren't undergoing disease-specific treatment. Results Our results showed that the pharyngeal barium residue after initial swallowing correlated better with the bulbar-related functional rating scales than that after multiple deglutition. This correlation was vague when the data from patients whose barium residue was &gt;50% were eliminated. In addition, evaluating the pharyngeal residue after initial swallowing proved to be the most sensitive method with regard to laryngeal penetration. Conclusion This study showed that the pharyngeal barium residue after initial swallowing was the most appropriate parameter for quantitatively assessing the degree of dysphagia using a videofluoroscopic swallowing study and suggests that this method may predict laryngeal penetration and aspiration in patients with spinal and bulbar muscular atrophy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hashizume</LastName><ForeName>Atsushi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banno</LastName><ForeName>Haruhiko</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsuno</LastName><ForeName>Masahisa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hijikata</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamada</LastName><ForeName>Shinichiro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inagaki</LastName><ForeName>Tomonori</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Keisuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, Innovation Center for Clinical Research, National Center for Geriatrics and Gerontology, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobue</LastName><ForeName>Gen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Division of Dementia and Neurodegenerative Disease, Nagoya University Graduate School of Medicine, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Intern Med</MedlineTA><NlmUniqueID>9204241</NlmUniqueID><ISSNLinking>0918-2918</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>25BB7EKE2E</RegistryNumber><NameOfSubstance UI="D001466">Barium Sulfate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001466" MajorTopicYN="N">Barium Sulfate</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003679" MajorTopicYN="N">Deglutition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003680" MajorTopicYN="N">Deglutition Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005471" MajorTopicYN="N">Fluoroscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007830" MajorTopicYN="N">Larynx</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011015" MajorTopicYN="N">Pneumonia, Aspiration</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">pharyngeal barium residue</Keyword><Keyword MajorTopicYN="N">spinal and bulbar muscular atrophy</Keyword><Keyword MajorTopicYN="N">swallowing dysfunction</Keyword><Keyword MajorTopicYN="N">videofluoroscopic swallowing study</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29021456</ArticleId><ArticleId IdType="pmc">PMC5742386</ArticleId><ArticleId IdType="doi">10.2169/internalmedicine.8799-16</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 18: 671-680, 1968.</Citation><ArticleIdList><ArticleId IdType="pubmed">4233749</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperfeld AD, Karitzky J, Brummer D, et al. . X-linked bulbospinal neuronopathy: Kennedy disease. Arch Neurol 59: 1921-1926, 2002.</Citation><ArticleIdList><ArticleId IdType="pubmed">12470181</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 112: 209-232, 1989.</Citation><ArticleIdList><ArticleId IdType="pubmed">2917278</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsuta N, Watanabe H, Ito M, et al. . Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain 129: 1446-1455, 2006.</Citation><ArticleIdList><ArticleId IdType="pubmed">16621916</ArticleId></ArticleIdList></Reference><Reference><Citation>Banno H, Katsuno M, Suzuki K, et al. . Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol 65: 140-150, 2009.</Citation><ArticleIdList><ArticleId IdType="pubmed">19259967</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Banno H, Suzuki K, et al. . Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 9: 875-884, 2010.</Citation><ArticleIdList><ArticleId IdType="pubmed">20691641</ArticleId></ArticleIdList></Reference><Reference><Citation>Logemann JA, Kahrilas PJ, Kobara M, Vakil NB. The benefit of head rotation on pharyngoesophageal dysphagia. Arch Phys Med Rehabil 70: 767-771, 1989.</Citation><ArticleIdList><ArticleId IdType="pubmed">2802957</ArticleId></ArticleIdList></Reference><Reference><Citation>Logemann JA, Pauloski BR, Rademaker AW, Colangelo LA, Kahrilas PJ, Smith CH. Temporal and biomechanical characteristics of oropharyngeal swallow in younger and older men. J Speech Lang Hear Res 43: 1264-1274, 2000.</Citation><ArticleIdList><ArticleId IdType="pubmed">11063246</ArticleId></ArticleIdList></Reference><Reference><Citation>Logemann JA. In: Evaluation and treatment of swallowing disorders. 2nd edition PRO-ED, Inc., Austin, TX, 1998: .</Citation></Reference><Reference><Citation>Takahashi N, Kikutani T, Tamura F, Groher M, Kuboki T. Videoendoscopic assessment of swallowing function to predict the future incidence of pneumonia of the elderly. J Oral Rehabil 39: 429-437, 2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">22329364</ArticleId></ArticleIdList></Reference><Reference><Citation>Pikus L, Levine MS, Yang YX, et al. . Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia. 180: 1613-1616, 2003.</Citation><ArticleIdList><ArticleId IdType="pubmed">12760930</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration-aspiration scale. Dysphagia 11: 93-98, 1996.</Citation><ArticleIdList><ArticleId IdType="pubmed">8721066</ArticleId></ArticleIdList></Reference><Reference><Citation>The ALS CNTF treatment study (ACTS) phase I-II Study Group The amyotrophic lateral sclerosis functional rating scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 53: 141-147, 1996.</Citation><ArticleIdList><ArticleId IdType="pubmed">8639063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohashi Y, Tashiro K, Itoyama Y, et al. . Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS (ALSFRS-R) Japanese version. No To Shinkei (in Japanese, Abstract in English) 53: 346-355, 2001.</Citation><ArticleIdList><ArticleId IdType="pubmed">11360474</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda E, Ohashi Y, Tashiro K, Mizuno Y, Kowa H, Yanagisawa N. Reliability and factorial structure of a rating scale for amyotrophic lateral sclerosis. No To Shinkei 53: 346-355, 2001(in Japanese, Abstract in English).</Citation><ArticleIdList><ArticleId IdType="pubmed">11360474</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyu M, Sobue G, Mukai E, et al. . Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann Neurol 32: 707-710, 1992.</Citation><ArticleIdList><ArticleId IdType="pubmed">1449253</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Rhodes LE, Kokkinis AD, White MJ, et al. . Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol 10: 140-147, 2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3056353</ArticleId><ArticleId IdType="pubmed">21216197</ArticleId></ArticleIdList></Reference><Reference><Citation>Warnecke T, Oelenberg S, Teismann I, et al. . Dysphagia in X-linked bulbospinal muscular atrophy (Kennedy disease). Neuromuscul Disord 19: 704-708, 2009.</Citation><ArticleIdList><ArticleId IdType="pubmed">19616433</ArticleId></ArticleIdList></Reference><Reference><Citation>Mano T, Katsuno M, Banno H, et al. . Tongue pressure as a novel biomarker of spinal and bulbar muscular atrophy. Neurology 82: 255-262, 2014.</Citation><ArticleIdList><ArticleId IdType="pubmed">24353334</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenhuber E, Schima W, Schober E, et al. . Videofluoroscopic assessment of patients with dysphagia: pharyngeal retention is a predictive factor for aspiration. AJR Am J Roentgenol 178: 393-398, 2002.</Citation><ArticleIdList><ArticleId IdType="pubmed">11804901</ArticleId></ArticleIdList></Reference><Reference><Citation>Logemann JA, Williams RB, Rademaker A, Pauloski BR, Lazarus CL, Cook I. The relationship between observations and measures of oral and pharyngeal residue from videofluorography and scintigraphy. Dysphagia 20: 226-231, 2005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1363251</ArticleId><ArticleId IdType="pubmed">16362511</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaves Rde D, Mangilli LD, Sassi FC, et al. . Two-dimensional perceptual videofluoroscopic swallowing analysis of the pharyngeal phase in patients older than 50 years. Arq Bras Cir Dig 26: 274-279, 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">24510034</ArticleId></ArticleIdList></Reference><Reference><Citation>Pikus L, Levine MS, Yang YX, et al. . Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia. Am J Roentgenol 180: 1613-1616, 2003.</Citation><ArticleIdList><ArticleId IdType="pubmed">12760930</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi N, Kikutani T, Tamura F, Groher M, Kuboki T. Videoendoscopic assessment of swallowing function to predict the future incidence of pneumonia of the elderly. J Oral Rehabil 39: 429-437, 2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">22329364</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>